Adenomatous Tumors of the Middle Ear: A Literature Review

Detalhes bibliográficos
Autor(a) principal: Cardoso,Flavia Amarante
Data de Publicação: 2017
Outros Autores: Monteiro,Eduardo Machado Rossi, Lopes,Livia Bernardi, Avila,Marianna Novaes da Costa, Scarioli,Bernardo Oliveira
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Archives of Otorhinolaryngology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642017000300308
Resumo: Abstract Introduction Neuroendocrine adenomas of the middle ear (NAME) are uncommon causes of middle ear masses. Mostly limited to case reports and small series, the literature is poor in providing an overall assessment of these tumors. Objective To review the current literature about all aspects of the disease, including its etiology, clinical manifestations, diagnosis, and treatment. Data Synthesis The pathogenesis of adenomatous tumors of the middle ear is not clear yet. One potential explanation is that an undifferentiated pluripotent endodermal stem cell may still be present in the middle ear mucosal surface, and may be the origin of the tumors. It typically appears as a nonspecific retrotympanic mass. The average age of onset for the disease is the fifth decade, and the most common clinical symptom is conductive hearing loss. Malign behavior is rare. There are numerous differential diagnoses of NAME. The final diagnosis depends on microscopic findings. The preoperative evaluation should include the use of computed tomography and magnetic resonance imaging. The adjunctive therapy of middle ear adenomatous tumors with radiotherapy, chemotherapy or somatostatin analogs is generally not recommended. Conclusion There is still much debate on pathogenesis and classification of NAME. Saliba’s classification is currently the most complete and preferable one. Aggressive surgical procedure with ossicular chain excision is the gold standard treatment. Followup with physical and radiological exams is mandatory, particularly if the first procedure was conservative, without the removal of the encased ossicles.
id FORL-1_334acc1a735934294dd00223a667f2c5
oai_identifier_str oai:scielo:S1809-48642017000300308
network_acronym_str FORL-1
network_name_str International Archives of Otorhinolaryngology
repository_id_str
spelling Adenomatous Tumors of the Middle Ear: A Literature Reviewmiddle earadenomaneuroendocrine tumorsAbstract Introduction Neuroendocrine adenomas of the middle ear (NAME) are uncommon causes of middle ear masses. Mostly limited to case reports and small series, the literature is poor in providing an overall assessment of these tumors. Objective To review the current literature about all aspects of the disease, including its etiology, clinical manifestations, diagnosis, and treatment. Data Synthesis The pathogenesis of adenomatous tumors of the middle ear is not clear yet. One potential explanation is that an undifferentiated pluripotent endodermal stem cell may still be present in the middle ear mucosal surface, and may be the origin of the tumors. It typically appears as a nonspecific retrotympanic mass. The average age of onset for the disease is the fifth decade, and the most common clinical symptom is conductive hearing loss. Malign behavior is rare. There are numerous differential diagnoses of NAME. The final diagnosis depends on microscopic findings. The preoperative evaluation should include the use of computed tomography and magnetic resonance imaging. The adjunctive therapy of middle ear adenomatous tumors with radiotherapy, chemotherapy or somatostatin analogs is generally not recommended. Conclusion There is still much debate on pathogenesis and classification of NAME. Saliba’s classification is currently the most complete and preferable one. Aggressive surgical procedure with ossicular chain excision is the gold standard treatment. Followup with physical and radiological exams is mandatory, particularly if the first procedure was conservative, without the removal of the encased ossicles.Fundação Otorrinolaringologia2017-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642017000300308International Archives of Otorhinolaryngology v.21 n.3 2017reponame:International Archives of Otorhinolaryngologyinstname:Fundação Otorrinolaringologia (FORL)instacron:FORL10.1055/s-0037-1601400info:eu-repo/semantics/openAccessCardoso,Flavia AmaranteMonteiro,Eduardo Machado RossiLopes,Livia BernardiAvila,Marianna Novaes da CostaScarioli,Bernardo Oliveiraeng2017-09-19T00:00:00Zoai:scielo:S1809-48642017000300308Revistahttps://www.scielo.br/j/iao/https://old.scielo.br/oai/scielo-oai.php||iaorl@iaorl.org||archives@internationalarchivesent.org||arquivos@forl.org.br1809-48641809-4864opendoar:2017-09-19T00:00International Archives of Otorhinolaryngology - Fundação Otorrinolaringologia (FORL)false
dc.title.none.fl_str_mv Adenomatous Tumors of the Middle Ear: A Literature Review
title Adenomatous Tumors of the Middle Ear: A Literature Review
spellingShingle Adenomatous Tumors of the Middle Ear: A Literature Review
Cardoso,Flavia Amarante
middle ear
adenoma
neuroendocrine tumors
title_short Adenomatous Tumors of the Middle Ear: A Literature Review
title_full Adenomatous Tumors of the Middle Ear: A Literature Review
title_fullStr Adenomatous Tumors of the Middle Ear: A Literature Review
title_full_unstemmed Adenomatous Tumors of the Middle Ear: A Literature Review
title_sort Adenomatous Tumors of the Middle Ear: A Literature Review
author Cardoso,Flavia Amarante
author_facet Cardoso,Flavia Amarante
Monteiro,Eduardo Machado Rossi
Lopes,Livia Bernardi
Avila,Marianna Novaes da Costa
Scarioli,Bernardo Oliveira
author_role author
author2 Monteiro,Eduardo Machado Rossi
Lopes,Livia Bernardi
Avila,Marianna Novaes da Costa
Scarioli,Bernardo Oliveira
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Cardoso,Flavia Amarante
Monteiro,Eduardo Machado Rossi
Lopes,Livia Bernardi
Avila,Marianna Novaes da Costa
Scarioli,Bernardo Oliveira
dc.subject.por.fl_str_mv middle ear
adenoma
neuroendocrine tumors
topic middle ear
adenoma
neuroendocrine tumors
description Abstract Introduction Neuroendocrine adenomas of the middle ear (NAME) are uncommon causes of middle ear masses. Mostly limited to case reports and small series, the literature is poor in providing an overall assessment of these tumors. Objective To review the current literature about all aspects of the disease, including its etiology, clinical manifestations, diagnosis, and treatment. Data Synthesis The pathogenesis of adenomatous tumors of the middle ear is not clear yet. One potential explanation is that an undifferentiated pluripotent endodermal stem cell may still be present in the middle ear mucosal surface, and may be the origin of the tumors. It typically appears as a nonspecific retrotympanic mass. The average age of onset for the disease is the fifth decade, and the most common clinical symptom is conductive hearing loss. Malign behavior is rare. There are numerous differential diagnoses of NAME. The final diagnosis depends on microscopic findings. The preoperative evaluation should include the use of computed tomography and magnetic resonance imaging. The adjunctive therapy of middle ear adenomatous tumors with radiotherapy, chemotherapy or somatostatin analogs is generally not recommended. Conclusion There is still much debate on pathogenesis and classification of NAME. Saliba’s classification is currently the most complete and preferable one. Aggressive surgical procedure with ossicular chain excision is the gold standard treatment. Followup with physical and radiological exams is mandatory, particularly if the first procedure was conservative, without the removal of the encased ossicles.
publishDate 2017
dc.date.none.fl_str_mv 2017-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642017000300308
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642017000300308
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1055/s-0037-1601400
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Fundação Otorrinolaringologia
publisher.none.fl_str_mv Fundação Otorrinolaringologia
dc.source.none.fl_str_mv International Archives of Otorhinolaryngology v.21 n.3 2017
reponame:International Archives of Otorhinolaryngology
instname:Fundação Otorrinolaringologia (FORL)
instacron:FORL
instname_str Fundação Otorrinolaringologia (FORL)
instacron_str FORL
institution FORL
reponame_str International Archives of Otorhinolaryngology
collection International Archives of Otorhinolaryngology
repository.name.fl_str_mv International Archives of Otorhinolaryngology - Fundação Otorrinolaringologia (FORL)
repository.mail.fl_str_mv ||iaorl@iaorl.org||archives@internationalarchivesent.org||arquivos@forl.org.br
_version_ 1754203975736885248